ALTEOGEN
Blood & Organ Banks · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
62 Yuseong-daero 1628beon-Gil Yuseong-gu...Phone Number
+82 423848780Website
www.alteogen.comRevenue
$5.7 MillionStock Symbol
196170Industry
ZI Rank: 4
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
4
3
4
4
About ALTEOGEN
Alteogen lnc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-Drug Conjugates (ADCs), biobetters and biosimilars. Alteogen's portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP-fusion and NexMab platform technology, respectively. It is also developing Eylea biosimilar. The company was founded in 2008 and listed in KOSDAQ (196170.KQ).Explore more
ALTEOGEN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ALTEOGEN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when ALTEOGEN launches new products
Congratulate Masked Content for being promoted to Masked Content at ALTEOGEN
Check if ALTEOGEN has recently received funding, and reach out quickly before it becomes old news!
Check out if ALTEOGEN is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ALTEOGEN has new funding data
Click to see if ALTEOGEN had a recent Job posting/layoffs
Earning: See what the market has to say on ALTEOGEN recently announced quarterly report
ALTEOGEN, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at ALTEOGEN
Find 2 more new buyers
Company Profile Activity
Activity Insights
ALTEOGEN is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
ALTEOGEN is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about ALTEOGEN.
ALTEOGEN Tech Stack
A closer look at the technologies used by ALTEOGEN
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Event
ALTEOGEN News & Media
Biogen Secures Exclusive Rights To Develop Subcutaneous Biologics Using Alteogen's ...
Biogen Secures Exclusive Rights To Develop Subcutaneous Biologics Using Alteogen’s ALT B4 PlatformAlteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc. for the development and commercialization of subcutaneous (SC) formulations of biologics utilizing ALT-B4 powered by Alteogen's Hybrozyme™ technology. Under the terms of the agreement, Biogen will obtain exclusiAlteogen Named Advanced Tech Firm by R&D Special Zone Foundation
The Innopolis Foundation announced on the 12th that it delivered an advanced technology enterprise designation certificate at Alteogen's headquarters in YuseongAlteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology
DAEJEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. Under the terms of the agreement, Tesaro will acquire world-wide rights to use...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ALTEOGEN
Sign Up For FreeTo access detailed company insights
Alteogen lnc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-Drug Conjugates (ADCs), biobetters and biosimilars. Alteogen's portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP-fusion and Ne... Read More
